Regeneron's experimental gene therapy improves hearing in one patient

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York

(Reuters) - Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved hearing to normal levels in a child within 24 weeks in an early to mid-stage study.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)